Literature DB >> 3119376

The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program.

H I Abdalla1, M Ah-Moye, P Brinsden, D L Howe, F Okonofua, I Craft.   

Abstract

The effect of the dose of human chorionic gonadotropin (hCG) on oocyte retrieval in an in vitro fertilization (IVF) program was studied. Following ovulation induction using clomiphene citrate and either pure follicle-stimulating hormone (FSH) or human menopausal gonadotropin (hMG), hCG was administered at a dose of 2000 IU (n = 88), 5000 IU (n = 110), and 10,000 IU (n = 104). There was a significantly lower successful oocyte recovery in patients who received 2000 IU of hCG (77.3%) compared with patients who received either 5000 IU of hCG (95.5%) or 10,000 IU of hCG (98.1%; P less than 0.001). There was no significant difference between 5000 or 10,000 IU of hCG. In patients who received 2000 IU of hCG, successful oocyte recovery was significantly lower when pure FSH was used (60%) compared with those who received hMG (84.1%; P less than 0.03). Patients have different thresholds for follicular response to hCG and the recommended minimum dose of hCG should be at least 5000 IU.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119376     DOI: 10.1016/s0015-0282(16)59591-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  19 in total

Review 1.  The empty follicle syndrome.

Authors:  A Kourtis; D Rousso; D Panidis
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

2.  Blastocyst utilization rates after continuous culture in two commercial single-step media: a prospective randomized study with sibling oocytes.

Authors:  Ioannis A Sfontouris; Efstratios M Kolibianakis; George T Lainas; Christos A Venetis; George K Petsas; Basil C Tarlatzis; Tryfon G Lainas
Journal:  J Assist Reprod Genet       Date:  2017-07-17       Impact factor: 3.412

3.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.

Authors:  Yanett Anaya; Douglas A Mata; Joseph Letourneau; Hakan Cakmak; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

Review 4.  Controversies in IVM.

Authors:  Shauna Leigh Reinblatt; Weon-Young Son; Einat Shalom-Paz; Hananel Holzer
Journal:  J Assist Reprod Genet       Date:  2011-05-10       Impact factor: 3.412

5.  The role of a human chorionic gonadotropin burst in in vitro fertilization.

Authors:  A Shulman; I Ben-Nun; Y Ghetler; M Yonish; S Mashiach
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

Review 6.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

7.  Recombinant or urinary human chorionic gonadotropin in ovulation induction?

Authors:  Gautam Allahbadia
Journal:  J Obstet Gynaecol India       Date:  2012-01-17

8.  Human chorionic gonadotropin (hCG) plasma levels at oocyte retrieval and IVF outcomes.

Authors:  R Matorras; A Meabe; R Mendoza; B Prieto; O Ramón; J Mugica; F Aspichueta; A Exposito
Journal:  J Assist Reprod Genet       Date:  2012-07-20       Impact factor: 3.412

9.  Gene expression profiling of granulosa cells from PCOS patients following varying doses of human chorionic gonadotropin.

Authors:  Serdar Coskun; Hasan H Otu; Khalid A Awartani; Laila A Al-Alwan; Saad Al-Hassan; Hend Al-Mayman; Namik Kaya; Mehmet S Inan
Journal:  J Assist Reprod Genet       Date:  2013-02-05       Impact factor: 3.412

10.  GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.

Authors:  Kathleen E O'Neill; Suneeta Senapati; Ivy Maina; Clarisa Gracia; Anuja Dokras
Journal:  J Assist Reprod Genet       Date:  2016-06-27       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.